Amalgamated Bank’s Boston Scientific Corp Position
Does Amalgamated Bank own Boston Scientific Corp (BSX)? Yes — 275.4K shares worth $17M (+0.13% of its 13F portfolio) as of Q1 2026, down from 280.7K shares the prior filed quarter.
Position Value
$17M
Q1 2026
Shares
275.4K
% of Portfolio
+0.13%
Quarters Held
29
currently held
Position History BSX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 275.4K | $17M | +0.13% |
| Q4 2025 | 280.7K | $27M | +0.19% |
| Q3 2025 | 297.8K | $29M | +0.21% |
| Q2 2025 | 301.0K | $32M | +0.25% |
| Q1 2025 | 292.4K | $30M | +0.25% |
| Q4 2024 | 289.5K | $26M | +0.21% |
| Q3 2024 | 296.3K | $25M | +0.20% |
| Q2 2024 | 296.8K | $23M | +0.19% |
| Q1 2024 | 303.2K | $21M | +0.18% |
| Q4 2023 | 356.9K | $21M | +0.16% |
| Q3 2023 | 375.4K | $20M | +0.17% |
| Q2 2023 | 370.9K | $20M | +0.16% |
| Q1 2023 | 375.9K | $19M | +0.16% |
| Q4 2022 | 373.7K | $17M | +0.15% |
| Q3 2022 | 369.7K | $14M | +0.14% |
| Q2 2022 | 364.5K | $14M | +0.13% |
| Q1 2022 | 357.7K | $16M | +0.12% |
| Q4 2021 | 383.2K | $16M | +0.12% |
| Q3 2021 | 385.1K | $17M | +0.14% |
| Q2 2021 | 398.1K | $17M | +0.14% |
| Q1 2021 | 78.0K | $3M | +0.11% |
| Q4 2020 | 81.0K | $3M | +0.11% |
| Q3 2020 | 81.2K | $3M | +0.13% |
| Q2 2020 | 81.4K | $3M | +0.13% |
| Q1 2020 | 232.0K | $8M | +0.19% |
| Q4 2019 | 239.6K | $11M | +0.20% |
| Q3 2019 | 230.9K | $9M | +0.20% |
| Q2 2019 | 184.2K | $8M | +0.18% |
| Q1 2019 | 199.8K | $8M | +0.19% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Amalgamated Bank’s full portfolio or all institutional holders of BSX.